Evidence map›Paper›PMID 31934263›Full record

ArticleThe World Allergy Organization journal2020

The burden of asthma in an inner-city area: A historical review 10 years after Isaac.

Blanca Estela Del-Rio-Navarro, Elsy Maureen Navarrete-Rodríguez, Arturo Berber, Nayely Reyes-Noriega, Luis García-Marcos Álvarez, Grupo GAN México, Grupo ISAAC México

Open access · goldAbstract read
In one paragraph

Article in The World Allergy Organization journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Changes in the national prevalence of asthma and coronavirus disease 2019 fatality: A population-based cross-sectional study.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Asthma-associated risk for COVID-19 development.The Journal of allergy and clinical immunology · 2020
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Blanca Estela Del-Rio-NavarroServicio de Alergia e Inmunología, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
Elsy Maureen Navarrete-RodríguezServicio de Alergia e Inmunología, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
Arturo BerberAsesor Externo, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
Nayely Reyes-NoriegaServicio de Alergia e Inmunología, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
Luis García-Marcos ÁlvarezUnit of Clinical Research, Cartagena and Department of Paediatrics, University of Murcia, Murcia, Spain.
Grupo GAN México, Grupo ISAAC México
Hospital Infantil de México Federico Gómez · MXUniversidad de Murcia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccording to the International Study of Asthma and Allergies in Childhood (ISAAC) methodology, in 2003, the prevalence of asthma symptoms in children 6-7 years old and adolescents 13-14 years old was 11.6% and 13.7%, respectively. Since then, the number of asthma cases has increased worldwide. The study was conducted in several districts in northern Mexico City to evaluate the prevalence of asthma in these age groups and examine possible risk factors. The data were compared to the 2003 results from the same area.

methodsThis was a comparative cross-sectional study following the official Global Asthma Network (GAN) methodology. The parents or guardians of participants completed a questionnaire that explored demographics, asthma symptoms, diagnoses, and possible risk factors. Central tendency measurements were determined for statistical analysis and chi-squared distribution for possible risk factors.

resultsA total of 2515 children aged 6-7 years and 3375 adolescents aged 13-14 years participated in the study. Compared to the ISAAC results, we found a greater prevalence of wheezing in both children (at some time in life, 19.2% vs. 27.1%; over the last year, 6.8% vs. 10.6%) and adolescents (at some time in life, 16.9% vs. 19.7%), and for children with an asthma diagnosis (4.5% vs. 5.1%). For both groups, the most common risk factor associated with wheezing was the presence of rhinitis symptoms.

conclusionsAsthma symptoms are highly prevalent in Mexico City, occurring in almost 20% of adolescents. Compared to a decade ago, there was a 7.9% increase in the prevalence of asthma symptoms in children. Almost half of the children and adolescents presenting with symptoms had experienced more than four episodes per year. However, less than 50% of children and adolescents with asthma symptoms had been diagnosed with this disorder, suggesting under-diagnosis.

Indexed as

AsthmaAtopic allergic diseasesGANGan, Global Asthma NetworkHimfg, Hospital Infantil de México Federico GómezISAACIsaac, International Study of Asthma and Allergies in ChildhoodRhinitisRisk factorsWheezing

Identifiers

PMID31934263
PMCPMC6953772
OpenAlexW2998909111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.